Pharmacology & Pharmacy

Volume 5, Issue 1 (January 2014)

ISSN Print: 2157-9423   ISSN Online: 2157-9431

Google-based Impact Factor: 0.70  Citations  h5-index & Ranking

Liver Cancer: Zheng Classification of Qi Stagnation and Blood Stasis

HTML  Download Download as PDF (Size: 165KB)  PP. 75-82  
DOI: 10.4236/pp.2014.51012    6,155 Downloads   8,613 Views  Citations
Author(s)

ABSTRACT

There is a long history of using traditional Chinese medicine in the treatment of liver cancer and other malignnancies. The classification of Qi stagnation and blood stasis (QSBS) is the most common Zheng in liver cancer. This Zheng is frequently encountered in liver cancers falling into the pathological category of massive type. QSBS is the principal mechanism for a tumor to develop. Liver cancer with QSBS Zheng has characteristic clinical manifestations. Evidence from ex vivo, in vivo and clinical studies has been reported for the identification and management of liver cancer with QSBS Zheng. This article reviews evidence-based study advances of QSBS Zheng, the most common Zheng encountered in liver cancer.

Share and Cite:

Y. Guan and Q. He, "Liver Cancer: Zheng Classification of Qi Stagnation and Blood Stasis," Pharmacology & Pharmacy, Vol. 5 No. 1, 2014, pp. 75-82. doi: 10.4236/pp.2014.51012.

Cited by

[1] Descriptions of qi deficiency and qi stagnation in traditional East Asian medicine: A comparison of Asian and Western sources
European Journal of Integrative …, 2022
[2] Understanding blood stasis in traditional East Asian medicine: a comparison of Asian and Western sources
2021
[3] Rapid determination of seven bioactive components in rat plasma by UPLC―MS/MS and its application to pharmacokinetic compatibility study of Jinlingzi San
2021
[4] Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery
2020
[5] The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
Frontiers in Pharmacology, 2018
[6] 3 种不同血瘀证动物模型的建立与评价
2016

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.